UK markets open in 7 hours 19 minutes
NIKKEI 225
38,460.08 +907.92 (+2.42%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.80 -0.01 (-0.01%) GOLD FUTURES
2,328.00 -10.40 (-0.44%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,475.83 -1,851.13 (-3.47%)
Haleon plc (HLN.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:35PM BST
| Previous close | 332.80 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 26,303,724 |
| Market cap | 30.1B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 29.96 |
| EPS (TTM) | 0.11 |
| Earnings date | 29 Feb 2024 |
| Forward dividend & yield | 0.06 (1.80%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | 363.53 |
Simply Wall St.Haleon plc (LON:HLN) Shares Could Be 24% Above Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, Haleon fair value estimate is UK£2.62 Haleon is estimated to...
ZacksPharma Stock Roundup: AZN to Buy FUSN, PFE to Sell Stake in HLN & Other Updates
AstraZeneca (AZN) is set to acquire Fusion Therapeutics (FUSN). Pfizer (PFE) plans to sell some shares of Haleon to lower stake from 32% to 24%.
ZacksGSK Outperforms Industry on Strength in Key Drugs & Vaccines
Strong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and positive pipeline updates should drive the stock in the future quarters.
© 2024 Yahoo. All rights reserved.